Clinically validated digital therapeutic launches with UKCA mark and NHS [...]

Q&A with Dr Jason Williams, founder of the Williams Cancer [...]

Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

New comic book aims to break stigma and showcase Omnipod [...]

Renowned neuromuscular clinician and researcher to shape care strategies and [...]

The International Finance Facility for Immunisation (IFFIm) today announced the [...]

Purpose, precision and progress: Jenny's advice on building a career that delivers. With more than 30 years of cross-functional experience spanning manufacturing, R&D, supply chain and commercial strategy, Jenny Gattari brings a rare depth of insight to her role as Global Business Development Lead at Pfizer CentreOne.

At a roundtable during the Veeva Summit being held in [...]

As psychedelic-assisted therapies move closer to mainstream psychiatric care, Cybin, [...]

The integration of artificial intelligence into pharmacovigilance is prompting a [...]